Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study
Benjamin Fisher, Antonia Szanto, Wan-Fai Ng, Michele Bombardieri, Maximilian Posch, Athena Papas, Arwa Farag, Thomas Daikeler, Bettina Bannert, Diego Kyburz, Alan Kivitz, Steven Carsons, David Isenberg, Francesca Barone, Simon Bowman, Pascal Espie, David Floch, Cyrielle Dupuy, Xiaohui Ren, Petra FaerberAndrew Wright, Hans-Ulrich Hockey, Michael Rotte, Julie Milojevic, Alexandre Avrameas, Marie-Anne Valentin, James Rush, Peter Gergely
Research output: Contribution to journal › Article › peer-review
18Citations
(Scopus)
917Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study'. Together they form a unique fingerprint.